Stay updated on Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Sign up to get notified when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.

Latest updates to the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.6.2 was added to the page's revision history, and the prior entry v3.6.0 was removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study page adds a recruitment status note indicating that recruitment has ended and introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the page revision to v3.6.0 and adjusting the Intervention/Treatment header formatting.SummaryDifference0.5%

- Check22 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing v3.5.4, indicating a minor revision of the record metadata.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a CMS/backend update. There is no apparent change to the study content or data presented on the page.SummaryDifference0.1%

- Check64 days agoChange DetectedUpdates the ClinicalTrials.gov page revision/version from **v3.5.2** to **v3.5.3**, reflecting a site release change rather than a change to the study details.SummaryDifference0.1%

- Check72 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.